Zicam acquired by Church & Dwight

Church & Dwight acquired Zicam, a US consumer healthcare / otc cold remedies brand, on Dec 1, 2020.

Transaction summary

Target
Zicam
Acquirer
Church & Dwight
Seller
-
Announced
2020-12-01
Geography
United States
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-19
Latest update
2026-10-21

Value and multiples

100% enterprise value

USD 530M

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

5.9x

Period not stated

Basis: FundComb estimate

EV / EBITDA

14.7x

EBITDA basis not stated

Basis: FundComb estimate

Amounts paid and other reported values

Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.

Consideration: USD 530M

Google News search result for Business Wire article titled 'Church & Dwight Acquires Zicam Brand for $530 Million' states $530 million; full article was not fetched.

Basis

  • Church & Dwight announced the acquisition for USD 530m (Business Wire, 1 December 2020). The 5.9x revenue and 14.7x EBITDA multiples come from FundComb’s comps spreadsheet and are not confirmed by a public source; the revenue, EBITDA and period behind them are not stated.

Source summary

Church & Dwight Acquires Zicam Brand for $530 Million - Business Wire

Confirmed
Open via Google News

Continue your research

Explore more comps →